Related Experiment Video
Updated: Jan 20, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Long noncoding RNA SNHG16 silencing inhibits the aggressiveness of gastric cancer via upregulation of microRNA-628-3p
Weifeng Pang1, Mingcui Zhai2, Yue Wang3
1Department of Internal Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Background:
MicroRNA-628-3p (miR-628) has been reported to play important roles in the progression of multiple human cancer types. Nonetheless, whether the expression profile of miR-628 is altered in gastric cancer remains unclear and whether its aberrant expression plays a crucial part in the aggressiveness of gastric cancer is yet to be determined. Therefore, in this study, we systematically investigated the involvement of miR-628 in gastric cancer progression.
Materials And Methods:
MiR-628 expression in gastric cancer tissues and cell lines were determined via reverse transcription-quantitative polymerase chain reaction (RT-qPCR). A CCK-8 assay, flow-cytometric analysis, Transwell assays, and a xenograft model experiment were performed to evaluate the influence of miR-628 overexpression on gastric cancer cells. Notably, the mechanisms underlying the tumor-suppressive activity of miR-628 in gastric cancer cells were explored by bioinformatics analysis, a luciferase reporter assay, RT-qPCR, and Western blotting.
Results:
MiR-628 expression was low in gastric cancer tissue samples and cell lines. The low expression of miR-628 was closely associated with the lymph node metastasis, invasive depth and TNM stage among patients with gastric cancer. Further clinical analysis indicated that patients with gastric cancer underexpressing miR-628 had a worse prognosis than did the patients with high miR-628 expression in the tumor. Overexpressed miR-628 restrained proliferation, migration, and invasion; induced apoptosis; and impaired tumor growth of gastric cancer cells. In addition, neuropilin 1 (NRP1) mRNA was validated as the direct target of miR-628 in gastric cancer. Long noncoding RNA small nucleolar RNA host gene 16 (SNHG16) was demonstrated to sponge miR-628 in gastric cancer. Moreover, miR-628 knockdown abrogated the influence of SNHG16 silencing on gastric cancer cells.
Conclusion:
Our findings elucidate how the SNHG16-miR-628-NRP1 pathway serves as a regulatory network playing crucial roles in gastric cancer progression, suggesting that this pathway may be a novel target of anticancer therapy.
Insights
Low microRNA-628-3p (miR-628) expression correlates with aggressive gastric cancer. Overexpressing miR-628 inhibits tumor growth, suggesting the SNHG16-miR-628-NRP1 pathway as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-628-3p (miR-628) is implicated in various cancers, but its role in gastric cancer is not well understood.
- Investigating miR-628's expression profile and functional significance in gastric cancer progression is crucial.
Purpose of the Study:
- To determine the expression levels of miR-628 in gastric cancer.
- To elucidate the functional role and underlying mechanisms of miR-628 in gastric cancer aggressiveness.
- To explore the potential of the miR-628 pathway as a therapeutic target.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for miR-628 expression analysis.
- Cellular assays (CCK-8, flow cytometry, Transwell) and xenograft models to assess miR-628's functional impact.
- Bioinformatics, luciferase reporter assays, RT-qPCR, and Western blotting to uncover molecular mechanisms.
Main Results:
- Gastric cancer tissues and cell lines exhibit significantly lower miR-628 expression.
- Low miR-628 expression is associated with advanced tumor stage, lymph node metastasis, and poorer patient prognosis.
- Overexpression of miR-628 suppressed proliferation, migration, invasion, and tumor growth while inducing apoptosis in gastric cancer cells.
- Neuropilin 1 (NRP1) was identified as a direct target, and long noncoding RNA SNHG16 acts as a sponge for miR-628.
Conclusions:
- The SNHG16-miR-628-NRP1 axis is a key regulatory network in gastric cancer progression.
- This pathway represents a promising novel therapeutic target for gastric cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Aggression
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Polymerase II Accessory Proteins
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...

